Agios Pharmaceuticals, Inc. · NASDAQ:AGIO
Goff Brian sold 19,068 Agios Pharmaceuticals, Inc. shares (Form 4)
Traded Apr 2, 2026 · Filed Apr 6, 2026
On Apr 2, 2026, Goff Brian (Director, Chief Executive Officer) sold 19,068 Agios Pharmaceuticals, Inc. shares at US$34.71 for US$662K under a trading plan, leaving 184,508 shares. Filed Apr 6, 2026 (Form 4).
- Sold
- 19,068 shares
- Price
- US$34.71
- Value
- US$662K
- Holding after
- 184,508 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 2, 2026 | Common stock | Option exercise | 25,528 | 190,076 | Direct | |
| Apr 2, 2026 | Common stock | Sale | 12,472 | US$34.71 | 177,604 | Direct |
| Apr 2, 2026 | Common stock | Option exercise | 13,500 | 191,104 | Direct | |
| Apr 2, 2026 | Common stock | Sale | 6,596 | US$34.71 | 184,508 | Direct |
Source
Related
- Agios Pharmaceuticals, Inc.
- Goff Brian
- Agios Pharmaceuticals, Inc. shareholders
- Form 4 · Gheuens Sarah · Aug 6, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 3, 2026
- Form 4 · Backstrom Jay T. · Jul 10, 2026
- Form 4 · Gheuens Sarah · Jul 2, 2026
- Schedule 13G · D. E. Shaw & Co., L.P. · Jul 2, 2026